Close filter

Kate Strayer-Benton

请联系我

Based in Boston, Kate Strayer-Benton is active in Egon Zehnder’s global Health Practice. Having spent her entire career both in and serving the healthcare sector, she draws on extensive management and consulting experience to provide executive search and leadership advisory support to healthcare clients both in the US and globally.

I’m passionate about aligning inspired leaders, effective teams, and organizations to make a difference for healthcare and the lives of people around the globe.

Prior to joining Egon Zehnder, Kate was the Senior Director of Business Development at the Dana-Farber Cancer Institute in Boston. Earlier she was with Momenta Pharmaceuticals in Cambridge as the Director of Corporate Development & Strategy. Kate launched her career at Health Advances, an independent life science strategy consulting firm in Weston, Massachusetts that was subsequently acquired by Parexel. In her last role at Health Advances, Kate served as the company’s Director of Business Development.

Kate earned a BA in psychology from Dartmouth College and an MBA from its Tuck School of Business. Supplementing her work as an Egon Zehnder consultant, she is passionate about advancing the careers and development of women via formal organizations, professional development programs, and mentoring. A native of New Hampshire, Kate enjoys spending time on Squam Lake and Lake Winnipesaukee and skiing and hiking in the White Mountains.

我的专长领域

联系我们
Send Kate a Message
浏览全部
智识与洞见

全球相关顾问

Golnaz Bahmanyar

Golnaz Bahmanyar

Middle East

Based in Dubai since 2008, Golnaz leads Egon Zehnder’s Consumer and Retail Practice in the Middle East, serving regional and multinational clients in… 阅读更多

Ashley Stephenson

Ashley Stephenson

Sydney

Ashley Stephenson is a trusted advisor to senior leaders, specializing in CEOs, general managers, and CHROs. Based in Sydney… 阅读更多

Alin Adomeit

Alin Adomeit

Frankfurt

Alin Adomeit is part of the firm’s Health Practice in Germany. She has deep experience in therapeutics, health-care services, and academia. 阅读更多

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top